UN / WORLD TB DAY ADVANCER
Download
There is no media available to download.
Share
STORY: UN / WORLD TB DAY ADVANCER
TRT: 1:23
SOURCE: WHO
RESTRICTIONS: NONE
LANGUAGE: NATS
DATELINE: FILE
2009, MADDOX CENTER, PHNOM PENH, CAMBODIA
1. Wide, exterior Maddox Center where children with HIV and TB are treated
2. Med shot, patient in bed
3. Med shot, care providers
4. Close-up, medicines
5. Close-up, doctor listening to patient’s heart and lungs
2009, SVEY RING PROVINCE, CAMBODIA
6. Med shot, nurses and patient on wheel chair
7. Med shot, nurse putting patient into bed
8. Med shot, nurse handing drugs to patient
2009, BEIJING CHEST HOSPITAL, CHINA
9. Med shot, chest X-rays
10. Med, doctor in lab
DATE UNKNOWN, LATVIA
11. Various shots, hospital wards with TB patients
DATE UNKNOWN, SLOVENIA
12. Various shots, TB patient at home
27 JUNE 2008, HAIN LIFESCIENCE, GERMANY
13. Various shots, laboratory worker carrying out preparations for MDR-TB using the new molecular line probe assay test
The World Health Organization (WHO) reported that in some areas of the world, one in four people with tuberculosis (TB) becomes ill with a form of the disease that can no longer be treated with standard drugs regimens.
WHO's latest report on TB called “Multidrug and Extensively Drug-Resistant Tuberculosis: 2010 Global Report on Surveillance and Response” estimated that 440,000 people had MDR-TB worldwide in 2008 and that a third of them died.
In sheer numbers, Asia bears the brunt of the epidemic. Almost 50 percent of MDR-TB cases worldwide are estimated to occur in China and India. In Africa, an estimated 69,000 cases have emerged, the vast majority of which went undiagnosed.
TB programmes face tremendous challenges in reducing MDR-TB rates. But there are encouraging signs that even in the presence of severe epidemics, governments and partners can turn around MDR-TB by strengthening efforts to control the disease and implementing WHO recommendations.
Two regions in the Russian Federation, Orel and Tomsk, have achieved a remarkable decline in MDR-TB in about five years. These regions join two countries, Estonia and Latvia, which have reversed rising high rates of MDR-TB, ultimately achieving a decline.
Progress remains slow in most other countries. Worldwide, of those patients receiving treatment, 60 percent were reported as cured. However, only an estimated seven percent of all MDR-TB patients are diagnosed.
There is an urgent need for improvements in laboratory facilities, access to rapid diagnosis and treatment with more effective drugs and regimens shorter than the current two years.
WHO is engaged in a five year project to strengthen TB laboratories with rapid tests in nearly 30 countries.
The report was launched in advance of World TB Day observed yearly on 24 March.









